Anti-parasitic drug Ivermectin is no longer allowed to be prescribed to COVID-19 patients.
The South African Health Products Regulatory Authority has terminated the controlled Compassionate Use Access Programme with immediate effect, saying there’s no credible evidence it helps treat COVID-19.
The authority had allowed it’s use in January last year amid public interest and reports of illicit Ivermectin entering the market.
It said that since the programme was introduced, more evidence has emerged around the efficacy of Ivermectin.
This includes the World Health Organization issuing an advisory that only recommended Ivermectin use within the context of clinical trials.
In South Africa, no further importation of unregistered Ivermectin products will be allowed and health facilities will no longer be enabled to hold bulk stock in anticipation of prescriptions.
Matters Related To Putin Not On BRICS Meeting Agenda – Pandor
Professor Taole Mokoena appointed As SA’s New Health Ombudsman
Glencore Ferroalloys Supports Local SMME In Steelpoort With Two 65-Seater Busses
Car-Sharing Could Hold The Key To The Future Of SA’s Mobility In Urban Areas
Debt Ceiling Deal Wins House Approval
SA’s Health System A ‘Dysfunctional Mess’ That Can’t Be Fixed – Makgoba
Zimbabweans In SA Have A Month To Find Alternative Ways To Regularise Stay
Power Grid Collapse ‘Highly Improbable’ – Ramokgopa
Government Is Intensifying The Fight Against Crime – Ramaphosa
Ending Loadshedding Is Ramaphosa’s Top Priority
HEALA Urges SA Public To Comment On Draft Food Labelling Regulations
There’s Been An Improvement in Implementation Of Energy Action Plan – Ramokgopa